Trials / Completed
CompletedNCT01491971
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients with Prostate Cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Degarelix |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2011-12-14
- Last updated
- 2013-12-12
Locations
15 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01491971. Inclusion in this directory is not an endorsement.